Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
67%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph early_phase_1
2
33%
Ph not_applicable
3
50%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 12 (33.3%)
Phase 11 (16.7%)
N/A3 (50.0%)

Trials by Status

withdrawn117%
recruiting117%
completed350%
terminated117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6